Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

INmune Bio Inc. INMB

Full chart Compare
Set alert

Price alert · INMB

All alert types
1.33 USD 0.00 (+0.00%)

At closeNov 4, 2026, 4:00 PM EST

1.33 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

Day range unavailable

1.09 52-week range 2.60
YTD
-14.74%
1 year
-22.67%

Financial health

Altman Z-Score

-9.30 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -0.8×
FY 2016: -147×FY 2017: -108×FY 2018: -7.2×FY 2019: -6.5×FY 2020: -17.0×FY 2021: -5.4×FY 2022: -4.2×FY 2023: -6.7×FY 2024: -2.2×FY 2025: -0.8×
FY 2016 5y median -4.2× FY 2025
P/S 829×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 18767×FY 2021: 909×FY 2022: 304×FY 2023: 1306×FY 2024: 6653×FY 2025: 829×
FY 2016 5y median 909× FY 2025
P/B 1.8×
FY 2016: -274×FY 2017: 5.0×FY 2018: 5.4×FY 2019: 2.5×FY 2020: 5.3×FY 2021: 2.1×FY 2022: 1.9×FY 2023: 5.3×FY 2024: 2.9×FY 2025: 1.8×
FY 2016 5y median 2.1× FY 2025
P/FCF -1.8×
FY 2016: -129×FY 2017: -104×FY 2018: -43.5×FY 2019: -11.1×FY 2020: -23.1×FY 2021: -3.8×FY 2022: -5.0×FY 2023: -16.9×FY 2024: -2.8×FY 2025: -1.8×
FY 2016 5y median -3.8× FY 2025
EV/EBITDA -0.4×
FY 2016: -829×FY 2017: 587×FY 2018: 3889287×FY 2019: -6.9×FY 2020: 0.0×FY 2021: -88.4×FY 2022: -57.0×FY 2023: -663×FY 2024: -1.7×FY 2025: -0.4×
FY 2016 5y median -57.0× FY 2025
EV/Sales 355×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 16784×FY 2021: 580×FY 2022: 205×FY 2023: 1142×FY 2024: 5186×FY 2025: 355×
FY 2016 5y median 580× FY 2025
FCF Yield -57.0%
FY 2016: -0.8%FY 2017: -1.0%FY 2018: -2.3%FY 2019: -9.0%FY 2020: -4.3%FY 2021: -26.4%FY 2022: -20.0%FY 2023: -5.9%FY 2024: -35.8%FY 2025: -57.0%
FY 2016 5y median -26.4% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -61738.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -111163.6%FY 2021: -16106.6%FY 2022: -6938.8%FY 2023: -19187.7%FY 2024: -304535.7%FY 2025: -61738.0%
FY 2016 5y median -19187.7% FY 2025
Net Margin -91866.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -109990.9%FY 2021: -16762.4%FY 2022: -7299.2%FY 2023: -19360.0%FY 2024: -300585.7%FY 2025: -91866.0%
FY 2016 5y median -19360.0% FY 2025
ROE -195.3%
FY 2016: 185.7%FY 2017: -4.6%FY 2018: -75.2%FY 2019: -32.5%FY 2020: -31.2%FY 2021: -37.8%FY 2022: -45.4%FY 2023: -78.7%FY 2024: -131.1%FY 2025: -195.3%
FY 2016 5y median -78.7% FY 2025
ROIC -125.7%
FY 2016: -113.0%FY 2017: -5.4%FY 2018: -75.2%FY 2019: -32.6%FY 2020: -31.4%FY 2021: -30.5%FY 2022: -34.2%FY 2023: -61.2%FY 2024: -131.3%FY 2025: -125.7%
FY 2016 5y median -61.2% FY 2025
ROA -142.0%
FY 2016: -61.3%FY 2017: -4.5%FY 2018: -71.6%FY 2019: -31.4%FY 2020: -29.8%FY 2021: -30.4%FY 2022: -33.4%FY 2023: -52.6%FY 2024: -106.4%FY 2025: -142.0%
FY 2016 5y median -52.6% FY 2025

Growth (YoY)

Revenue 257.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 1545.5%FY 2022: 106.6%FY 2023: -58.6%FY 2024: -91.0%FY 2025: 257.1%
FY 2016 FY 2025
Operating Income 27.6%
FY 2016: -364.5%FY 2017: -332.2%FY 2018: -1168.1%FY 2019: 37.7%FY 2020: -57.7%FY 2021: -138.4%FY 2022: 11.0%FY 2023: -14.6%FY 2024: -43.4%FY 2025: 27.6%
FY 2016 FY 2025
EPS (diluted) 11.8%
FY 2016: -453.1%FY 2017: -36.7%FY 2018: -1398.0%FY 2019: 19.8%FY 2020: -13.5%FY 2021: -86.1%FY 2022: 19.1%FY 2023: -9.9%FY 2024: -26.3%FY 2025: 11.8%
FY 2016 FY 2025
Free Cash Flow 29.2%
FY 2016: -1651.7%FY 2017: -171.5%FY 2018: -138.9%FY 2019: -161.5%FY 2020: -66.1%FY 2021: -386.4%FY 2022: 47.9%FY 2023: 47.2%FY 2024: -178.5%FY 2025: 29.2%
FY 2016 FY 2025

Financial Health

Current Ratio 3.6×
FY 2016: 0.8×FY 2017: 6.1×FY 2018: 1.0×FY 2019: 11.1×FY 2020: 13.5×FY 2021: 19.0×FY 2022: 5.9×FY 2023: 2.2×FY 2024: 3.1×FY 2025: 3.6×
FY 2016 5y median 3.6× FY 2025
Quick Ratio 3.6×
FY 2016: 0.8×FY 2017: 6.1×FY 2018: 1.0×FY 2019: 1109×FY 2020: 13.5×FY 2021: 20.2×FY 2022: 5.9×FY 2023: 2.2×FY 2024: 3.1×FY 2025: 3.6×
FY 2016 5y median 3.6× FY 2025
Debt / Equity 0.0×
FY 2016: -2.3×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: -4.2×FY 2017: -9.1×FY 2018: -8096×FY 2019: 0.9×FY 2020: 0.0×FY 2021: 50.2×FY 2022: 27.3×FY 2023: 95.2×FY 2024: 0.5×FY 2025: 0.5×
FY 2016 5y median 27.3× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31